2020
DOI: 10.3390/molecules25184337
|View full text |Cite
|
Sign up to set email alerts
|

Sulphamoylated Estradiol Analogue Induces Reactive Oxygen Species Generation to Exert Its Antiproliferative Activity in Breast Cancer Cell Lines

Abstract: 2-Methoxyestradiol (2ME), a 17β-estradiol metabolite, exerts anticancer properties in vitro and in vivo. To address 2ME’s low bioavailability, research led to the in silico design of sulphamoylated 2ME analogues. However, the role of oxidative stress induced in the activity exerted by sulphamoylated compounds remains elusive. In the current study, the influence of 2-Ethyl-17-oxoestra-1,3,5(10)-trien-3-yl sulphamate (ESE-one) on reactive oxygen species (ROS) induction and its effect on cell proliferation, as we… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

0
7
0

Year Published

2021
2021
2023
2023

Publication Types

Select...
4

Relationship

1
3

Authors

Journals

citations
Cited by 4 publications
(7 citation statements)
references
References 36 publications
0
7
0
Order By: Relevance
“…Sulfamoylated estradiol analogs have been explored in recent years and studies have reported that these derivatives exert antiproliferative and antimitotic activity resulting in cell death induction in various tumorigenic cell lines [ 2 , 3 , 4 , 5 , 6 , 7 , 8 ]. Recent studies have demonstrated that ESE-one possesses antiproliferative activity that is dependent on oxidative stress induced by increased peroxyl radical, superoxide anion and hydrogen peroxide [ 9 ]. However, the role of these reactive oxygen species on mitochondrial membrane potential and cell cycle progression remain unknown as well as the role of possible dysregulation of antioxidant enzymes by the sulfamoylated estradiol compound in breast tumorigenic cell lines.…”
Section: Discussionmentioning
confidence: 99%
See 3 more Smart Citations
“…Sulfamoylated estradiol analogs have been explored in recent years and studies have reported that these derivatives exert antiproliferative and antimitotic activity resulting in cell death induction in various tumorigenic cell lines [ 2 , 3 , 4 , 5 , 6 , 7 , 8 ]. Recent studies have demonstrated that ESE-one possesses antiproliferative activity that is dependent on oxidative stress induced by increased peroxyl radical, superoxide anion and hydrogen peroxide [ 9 ]. However, the role of these reactive oxygen species on mitochondrial membrane potential and cell cycle progression remain unknown as well as the role of possible dysregulation of antioxidant enzymes by the sulfamoylated estradiol compound in breast tumorigenic cell lines.…”
Section: Discussionmentioning
confidence: 99%
“…Previous research has indicated that sulfamoylated estradiol compounds exert antiproliferative and antimitotic activity in several tumorigenic cell lines [ 7 ]. Recent findings reported that ESE-one, a representative sulfamoylated estradiol analog, reduces cell growth and induces cell rounding by means of increased quantities of superoxide anion, peroxyl radical and hydrogen peroxide [ 9 ]. The current study suggests that ESE-one induces a time-dependent accumulation of cells in the G 2 /M and G 1 phase that is partially impaired by tiron and trolox and DMTU suggesting that superoxide anion, hydrogen peroxide and peroxyl radical is required for the effects exerted by ESE-one resulting in antimitotic activity and induction of cell death.…”
Section: Discussionmentioning
confidence: 99%
See 2 more Smart Citations
“…Compared with BTZ alone, representing the first PI available for MM patients, they showed that 2-methoxyestradiol (2ME), which is a natural estrogen metabolite, induced a higher rate of MM cell death, due to increases in the mitochondrial ROS and Ca 2+ levels in the cells, the activation of c-Jun N-terminal kinase (JNK), and mitogen-activated protein kinase kinase 4/7 (MKK4/7) [ 17 ]. The capability of 2ME to increase the death of cancer cells has also been proved to be powerful against other types of tumor, such as ovarian, lung, breast, and colorectal tumors [ 13 , 18 , 19 , 20 , 21 ].…”
Section: Re-sensitization To Chemotherapy Through Caspase-independmentioning
confidence: 99%